You are here:
Consumer Guide to Diabetes Products
Sulphonylureas
This medication stimulates the pancreas to produce more insulin.
These drugs can produce hypoglycaemia (abnormally low blood sugar levels).
Other side effects that may occur are development of skin allergies, tummy upsets, and increased sensitivity to light.
Rare but serious side effects include liver problems, fever or chills, and increased ease of bruising.
| Pharmaceutical Name | Manufacturer's Name | Manufacturer/ Distributor | Presentation | Availability | Subsidy Level |
|---|---|---|---|---|---|
| Glibenclamide | Gliben1![]() |
Pacific Pharmaceuticals |
|
Three month supply can be dispensed all-at-once | Fully subsidised |
| Gliclazide | Apo-Gliclazide |
Apotex NZ Ltd |
|
Three month supply can be dispensed all-at-once | Fully subsidised |
| Glipizide | Minidiab2 | Pfizer |
|
Three month supply can be dispensed all-at-once | Fully subsidised |
| Glibenclamide | Daonil | Sanofi Aventis |
|
Three month supply can be dispensed all at once | Fully subsidised. |
View information about other oral medications:
Or return to Introduction & Contents page »
-
For detailed information follow the link to Medsafe Consumer Medicines Information, and enter "Gliben" in the search field.↩
-
For detailed information follow the link to Medsafe Consumer Medicines Information, and enter "Minidiab" in the search field.↩
